Shilpa Medicare · NSE: SHILPAMED · BSE: 530549

Q1 FY27 results · Apr–Jun 2026

Shilpa Medicare reported revenue from operations of ₹465.78 crore (up 44.9% from Q1 FY26) and net profit of ₹100.88 crore (up 115.2% from Q1 FY26) for Q1 FY27 (Apr–Jun 2026), on a consolidated basis.

Consolidated · ₹ crore
ItemQ1 FY27Q1 FY26YoYQ4 FY26QoQ
Revenue from operations465.78321.46+44.9%436.99+6.6%
Other income3.136.38−50.9%1.67+87.4%
Total income468.91327.84+43.0%438.66+6.9%
Profit before share of associates & JVs and tax92.0950.31+83.0%120.45−23.5%
Share of profit/(loss) of associates & JVs5.96(0.73)0.00
Net profit for the period100.8846.89+115.2%107.79−6.4%
EPS, basic (₹)5.164.79not comparable5.51not comparable
Net margin (%)21.714.624.7

This company reports a share of profit/(loss) from associates and joint ventures. BSE’s filing format records that share after tax, so it is shown on its own line. The company’s own statement may add it before its “profit before tax” line.

Standalone · ₹ crore
ItemQ1 FY27Q1 FY26YoYQ4 FY26QoQ
Revenue from operations189.0492.43+104.5%201.11−6.0%
Other income9.5617.79−46.3%6.89+38.8%
Total income198.60110.22+80.2%208.00−4.5%
Profit before tax51.0614.79+245.4%78.02−34.6%
Net profit for the period64.9220.70+213.7%70.97−8.5%
EPS, basic (₹)3.322.12not comparable3.63not comparable
Net margin (%)34.322.435.3
Consolidated
Filed with BSE
05 Aug 2026, 14:48 IST
Board meeting
05 Aug 2026
Period
01 Apr 2026 to 30 Jun 2026
Review status
Unaudited
Source
XBRL filing on BSE
Standalone
Filed with BSE
05 Aug 2026, 14:48 IST
Board meeting
05 Aug 2026
Period
01 Apr 2026 to 30 Jun 2026
Review status
Unaudited
Source
XBRL filing on BSE